Know Cancer

or
forgot password

Effects of Chemotherapy on Circulating Tumor Cells and Recurrences in IB-IIA Cervical Cancer Patients With Intermediate Risk Factors After Radical Surgery


N/A
18 Years
70 Years
Not Enrolling
Female
Cervical Cancer

Thank you

Trial Information

Effects of Chemotherapy on Circulating Tumor Cells and Recurrences in IB-IIA Cervical Cancer Patients With Intermediate Risk Factors After Radical Surgery


Inclusion Criteria:



- Patients with histologically confirmed Ib~IIa (FIGO)cervical carcinoma without
previous treatments

- Age between 18-70

- With the presence of these three pathological risk factors after radical surgery:(1)
positive lymphatic vascular space,(2)outer one-third invasion of the cervical stroma,
(3) bulky tumor≥4cm

- At least 3 months of disease-free survival

Exclusion Criteria:

- The presence of other uncontrolled life-threatening disease (Suffering from
myocardial infarction or stroke, or unstable angina, decompensated heart failure, or
a history of deep vein thrombosis)

- Receiving other anti-cancer therapy, such as traditional Chinese drug

- Don't be able to finish the whole treatment(chemotherapy or radiotherapy)

- liver dysfunction (ALT、AST>2.5×ULN)

- renal dysfunction (Creatinine>1.5×ULN)

- WBC<4,000/mm3 or PLT<100,000/mm3

- Received preoperative radiotherapy

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

The occurrence rate of CTCs, distant metastasis-free survival, disease-free survival, metastatic sites

Outcome Time Frame:

3 years

Safety Issue:

Yes

Principal Investigator

Ma Ding, M.D.

Investigator Role:

Study Director

Investigator Affiliation:

Tongji Hospital of HUST

Authority:

China: Ministry of Health

Study ID:

GM2010-02

NCT ID:

NCT01063296

Start Date:

March 2010

Completion Date:

January 2014

Related Keywords:

  • Cervical Cancer
  • cervical cancer
  • Uterine Cervical Neoplasms
  • Neoplastic Cells, Circulating
  • Recurrence

Name

Location